Product Description:

Regorafenib  is an oral multi-kinase inhibitor  involved in normal cellular functioning and in pathological processes such as oncogenesis, tumor angiogenesis, metastasis, and tumor immunity.It is used in the therapy of metastatic colorectal cancer , gastrointestinal stromal tumor and  hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib.

Product Features:

Product Name : Regonix
Generic Name :Regorafenib
Formulation : Tablet
Available size : 28’s
Strengths : 40mg
Registrations : Available
Website :

Categories: Anti-Cancer